Spinal Muscular Atrophy Support Team Guide: Equipment, Therapy, and Carer Training Providers

Key Points

• SMA qualifies for NDIS as a genetic condition causing permanent impairment; plan size varies significantly by SMA type, with type 1 requiring the most comprehensive and high-cost supports
• Disease-modifying treatments (nusinersen, risdiplam, onasemnogene) have changed SMA trajectories significantly; plans should be reviewed regularly to account for treatment-related improvements in function
• Respiratory management is the most important clinical priority in SMA type 1 and 2; a respiratory physiotherapist provides ongoing monitoring, airway clearance training, and carer education in respiratory equipment
• Power wheelchair assessment for SMA is complex, requiring comprehensive postural support prescription; the OT assessment should anticipate progression over two to three years
• Carers (family and support workers) need formal training in assisted cough, ventilator management, safe transfers, and positioning before working independently with a person with SMA
• SMA Australia is the national patient organisation providing peer support, information, and connection to services for families

---

Spinal Muscular Atrophy and Home Support

Spinal muscular atrophy is a genetic neuromuscular condition caused by mutations in the SMN1 gene, resulting in loss of motor neurons in the spinal cord and brainstem. The condition causes progressive muscle weakness affecting mobility, breathing, swallowing, and speech to varying degrees depending on SMA type.

SMA is now identified through Australia’s newborn screening program, allowing early access to disease-modifying treatments. This has changed the prognosis significantly for many children with SMA, particularly those treated in the first weeks of life. However, older people with SMA diagnosed before these treatments were available, and those with severe SMA type 1 where treatment response is variable, continue to require comprehensive ongoing support.

This guide covers the NDIS pathway, the multidisciplinary provider team, respiratory and equipment priorities, carer training, and the practical elements of building a support team matched to the person’s SMA type and current function.

---

NDIS Funding for SMA

SMA is a qualifying condition for NDIS given its genetic basis and permanent functional impairment. Plans include supports across all three budget categories.

Core Supports:

• Personal care and daily living support worker hours
• Community access and social participation
• Supported Independent Living (SIL) for those with high overnight support needs
• Transport

Capacity Building Supports:

• Physiotherapy (including respiratory physiotherapy)
• Occupational therapy
• Speech pathology
• Psychology
• Support coordination

Capital Supports:

• Power wheelchairs and complex seating systems
• Respiratory equipment (cough assist, CPAP, BiPAP)
• Home modifications (ramps, ceiling hoists, accessible bathrooms)
• Communication technology (AAC devices, eye gaze systems)

Plan size varies significantly by SMA type and current function. For SMA type 1 with high support needs including overnight ventilation and 24-hour care, annual plans may exceed $200,000. SMA type 3 with preserved walking function may have significantly smaller plans focused on therapy, community access, and equipment.

From mid-2026, the NDIA is rolling out a new planning framework. Families should expect potential changes to how plans are developed and should work with an experienced support coordinator to navigate these changes.

---

The SMA Provider Team

Physiotherapist (Neuromuscular and Respiratory)

A physiotherapist with neuromuscular disease experience is central to the SMA support team.

Respiratory physiotherapy:

For SMA type 1 and 2, respiratory muscle weakness reduces the ability to breathe deeply and cough effectively. The respiratory physiotherapist:

• Monitors respiratory function (peak cough flow, spirometry, overnight oxygen saturation)
• Teaches and supervises airway clearance techniques including manually assisted cough (manual chest compression to enhance cough force) and mechanical insufflation-exsufflation (cough assist device)
• Trains carers in these techniques and in ventilator management
• Recommends when to introduce nocturnal ventilation and provides training for its use
• Liaises with the hospital respiratory team for clinical escalation

Gross motor and musculoskeletal physiotherapy:

• Range of motion maintenance (preventing contractures in affected limbs)
• Positioning and postural management (to reduce scoliosis progression)
• Safe manual handling training for carers
• Community exercise guidance within the limits of preserved muscle function

Occupational Therapist

The OT’s primary role in SMA is assistive technology prescription, particularly for mobility and communication equipment, and home modification.

Power wheelchair assessment: For SMA type 1 and 2, this is the most significant equipment assessment. The OT works with a rehabilitation engineer or AT supplier to prescribe a complex rehabilitation chair with:

• Comprehensive postural support (tilt-in-space, recline, lateral supports, head support)
• Drive controls matched to available motor function (joystick, head array, or switch access for limited upper limb function)
• Integration with AAC device or computer access
• Transport compatibility
• Indoor and outdoor performance requirements

The assessment should look ahead to likely changes over the next two to three years, as the wheelchair prescription should accommodate anticipated progression.

Home modifications: Ramps, ceiling hoists, accessible bathroom, and any structural modifications to support safe care and mobility in the home.

Upper limb equipment: For SMA type 2 with preserved but weak upper limb function: arm supports (mobile arm orthoses), adaptive computer access, and aids for self-care tasks.

Speech Pathologist

AAC (Augmentative and Alternative Communication):

For SMA type 1 and high-level SMA type 2 with limited upper limb function, communication requires AAC. The speech pathologist:

• Assesses communication needs and available motor access (eye gaze, switch, head movement)
• Prescribes and programmes an appropriate communication device
• Trains the person, family carers, and support workers in device use
• Reviews and updates the AAC system as the person’s communication needs and motor access change

Eye gaze technology, which enables communication and computer access through eye movement, is frequently used in SMA type 1.

Dysphagia (swallowing):

Swallowing difficulties are present in SMA type 1 and some type 2 participants. A swallowing assessment identifies aspiration risk and guides safe feeding strategies, including recommended diet textures and fluid consistencies (IDDSI framework) and positioning for mealtimes.

Community Nurse

For people on ventilatory support or with complex health needs, community nursing provides:

• Clinical monitoring of respiratory status and equipment
• Training of carers and support workers in nursing procedures (suctioning in tracheostomy management, clinical observation)
• Liaison with the hospital specialist team
• Assessment and management of skin integrity and pressure injury prevention

Support workers must receive nursing delegation training before managing respiratory equipment or any nursing procedures.

Psychologist

Living with a progressive neuromuscular condition has a significant psychological impact on both the person with SMA and their family. Psychology through Medicare (GP Mental Health Care Plan) or NDIS Capacity Building supports adjustment, mental health, and quality of life.

---

Carer Training: A Clinical Priority

The safety and wellbeing of a person with SMA type 1 or 2 depends significantly on the quality of carer training. Both family carers and paid support workers must receive formal training before working independently in key areas.

Skill	Trained by	When essential
Manually assisted cough	Respiratory physiotherapist	SMA type 1 and 2
Cough assist device operation	Respiratory physiotherapist	When device prescribed
Ventilator management	Respiratory physiotherapist and nurse	Nocturnal or daytime ventilation
Safe manual handling and transfers	Physiotherapist	All SMA type 1 and 2
Positioning and postural management	Physiotherapist and OT	All SMA type 1 and 2
AAC device operation	Speech pathologist	When device prescribed
Safe feeding and mealtime positioning	Speech pathologist	Dysphagia present
Suctioning (tracheostomy)	Community nurse	Invasive ventilation

Training should be documented and refreshed at least annually. New support workers must complete training before working independently; they should not be expected to learn on the job in a clinical situation.

---

Disease-Modifying Treatment and NDIS Planning

The availability of disease-modifying treatments (DMT) for SMA has changed the landscape considerably since 2019. Nusinersen (Spinraza), onasemnogene abeparvovec (Zolgensma), and risdiplam (Evrysdi) are now funded through the Pharmaceutical Benefits Scheme (PBS) for eligible patients.

For children who receive DMT early (particularly in the first weeks after a newborn screening positive result), functional gains may be substantial: some children with genetically confirmed SMA type 1 have achieved independent sitting and, in some cases, walking, which was not previously possible.

NDIS plans for children receiving DMT should be reviewed regularly (at least annually, or more frequently if functional changes are occurring rapidly) to ensure support levels are appropriate to the person’s current capacity. Plans should be built to adapt upward or downward based on functional trajectory.

---

Key Resources

• SMA Australia - national patient organisation, peer support, and information
• AUSNMD (Australian Neuromuscular Disease Network) - clinical resources and SMA information for families
• Together in SMA - clinical information on SMA care standards
• NDIS Assistive Technology information - official NDIS guidance on equipment funding

---

Connecting with SMA Support Providers

Carevo connects families with spinal muscular atrophy to physiotherapists, OTs, speech pathologists, community nurses, and NDIS-registered carer training providers across Australia.

Find an SMA support provider through Carevo